$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
Johnson & Johnson to Return to Tort System to Defeat Meritless Talc Claims
10:20pm, Monday, 31'st Mar 2025
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Today, the U.S. Bankruptcy Court for the Southern District of Texas denied the request by Johnson & Johnson (NYSE: JNJ) (the “Company”) subsidiary Red River T
Johnson & Johnson to Return to Tort System to Defeat Meritless Talc Claims
10:20pm, Monday, 31'st Mar 2025
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Today, the U.S. Bankruptcy Court for the Southern District of Texas denied the request by Johnson & Johnson (NYSE: JNJ) (the “Company”) subsidiary Red River T
US judge rejects J&J's $10 billion baby powder settlement
08:06pm, Monday, 31'st Mar 2025
A U.S. bankruptcy judge on Monday rejected Johnson & Johnson's $10 billion proposal to end lawsuits alleging that its baby powder and other talc products cause ovarian cancer, marking the third time t
US judge rejects J&J's $10 billion baby powder settlement
07:57pm, Monday, 31'st Mar 2025
A U.S. bankruptcy judge on Monday rejected Johnson & Johnson's $10 billion proposal to end lawsuits alleging that its baby powder and other talc products cause ovarian cancer, marking the third time t
Best Dividend Aristocrats For April 2025
04:07pm, Monday, 31'st Mar 2025
Dividend Aristocrats are outperforming the S&P 500 in 2025, demonstrating resilience, with NOBL up 1.78% YTD versus SPY's 4.9% decline. Top performers include Consolidated Edison (+22.98%), Brown & Br
Why Johnson & Johnson (JNJ), United Health (UNH) And Procter & Gamble (PG) Are Holding the S&P 500 From Dropping More
01:58pm, Monday, 31'st Mar 2025
As President Trump's April 2nd “Liberation Day” approaches, the stock market has been selling off due to uncertainties on the impact of the tariff policy implementation intended to even out the pr
Are You Looking for a High-Growth Dividend Stock?
12:45pm, Monday, 31'st Mar 2025
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?
JNJ's Rybrevant-Lazcluze Combo Outshines AZN's Tagrisso in Lung Cancer
10:42am, Monday, 31'st Mar 2025
Study investigators expect that J&J's combo drug can extend overall survival by at least a year over the current standard of care in certain NSCLC patients.
Procter & Gamble, Johnson & Johnson Among 10 Companies To Announce Dividend Increases In First Half Of April
05:52pm, Sunday, 30'th Mar 2025
This is my latest article where I provide predictions of upcoming dividend increases from companies with long-term dividend growth histories. A slow March brought mid-single digit percentage dividend
These 10 Stocks Have Increased Dividends For Over 60 Consecutive Years. Should You Buy Them Now?
11:10am, Sunday, 30'th Mar 2025
Dividend King stocks with over a half century of dividend increases can often fall into a rut over time.
If I Could Only Choose 5 Dividend Stocks For My Retirement Portfolio
07:00am, Saturday, 29'th Mar 2025
When seeking companies for your retirement portfolio, I suggest focusing on companies with significant competitive advantages, a strong balance sheet and the capacity to pay sustainable dividends. I a
3 Relatively Safe Stocks to Buy Right Now
06:45am, Saturday, 29'th Mar 2025
Investing in stocks comes with risks. There's no way around that fact.
Johnson & Johnson Needs Time To Consolidate (Technical Analysis And Downgrade)
04:40pm, Friday, 28'th Mar 2025
Two recent catalysts, one technical and one fundamental, have promoted me to adjust my rating on JNJ to a HOLD from my earlier buy rating. Technical trading patterns signal that JNJ is entering a cons
Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case
12:19pm, Friday, 28'th Mar 2025
A federal judge ordered a Johnson & Johnson unit on Friday to pay the U.S. government $1.64 billion after a jury found it liable in a whistleblower lawsuit for illegally promoting the HIV drugs Prezis
Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know
10:05am, Thursday, 27'th Mar 2025
Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.
Sign In
Buy JNJ